These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 4453617
1. Inhibition by sulfhydryl agents of arachidonic acid-induced platelet aggregation and release of potential inflammatory substances. Vargaftig BB, Tranier Y, Chignard M. Prostaglandins; 1974 Oct 25; 8(2):133-56. PubMed ID: 4453617 [No Abstract] [Full Text] [Related]
2. Platelet aggregation induced by arachidonic acid is accompanied by release of potential inflammatory mediators distinct from PGE2 and PGF2. Vargaftig BB, Zirinis P. Nat New Biol; 1973 Jul 25; 244(134):114-6. PubMed ID: 4517254 [No Abstract] [Full Text] [Related]
3. Substances that increase the cyclic AMP content prevent platelet aggregation and the concurrent release of pharmacologically active substances evoked by arachidonic acid. Vargaftig BB, Chignard M. Agents Actions; 1975 May 25; 5(2):137-44. PubMed ID: 51579 [Abstract] [Full Text] [Related]
4. Blockade by metal complexing agents and by catalase of the effects of arachidonic acid on platelets: relevance to the study of anti-inflammatory mechanisms. Vargaftig BB, Tranier Y, Chignard M. Eur J Pharmacol; 1975 Aug 25; 33(1):19-29. PubMed ID: 1175685 [Abstract] [Full Text] [Related]
5. Inhibition by non-steroid anti-inflammatory agents of rabbit aorta contracting activity generated in blood by slow reacting substance C. Ferreira SH, Vargaftig BB. Br J Pharmacol; 1974 Apr 25; 50(4):543-51. PubMed ID: 4155653 [Abstract] [Full Text] [Related]
6. Dog platelets fail to aggregate when they form aggregating substances upon stimulation with arachidonic acid. Chignard M, Vargaftig B. Eur J Pharmacol; 1976 Jul 25; 38(1):7-18. PubMed ID: 954835 [Abstract] [Full Text] [Related]
7. Endoperoxides and thromboxanes. Structural determinants for platelet aggregation and vasoconstriction. Raz A, Minkes MS, Needleman P. Biochim Biophys Acta; 1977 Aug 24; 488(2):305-11. PubMed ID: 560869 [No Abstract] [Full Text] [Related]
8. Blockage of partially obstructed coronary arteries with platelet thrombi: comparison between its prevention with cyclooxygenase inhibitors versus prostacyclin. Aiken JW, Shebuski RJ, Gorman RR. Adv Prostaglandin Thromboxane Res; 1980 Aug 24; 7():635-9. PubMed ID: 6245568 [Abstract] [Full Text] [Related]
9. Inhibition of platelet adhesion to aortic subendothelium by indomethacin--an effect unrelated to inhibition of arachidonic acid metabolism. Menys VC, Davies JA. Thromb Res; 1985 Jan 01; 37(1):225-9. PubMed ID: 3920777 [No Abstract] [Full Text] [Related]
10. Alterations in pharmacological receptor activities of rabbit arteries by sulfhydryl reagents. Asano M, Hidaka H. Jpn J Pharmacol; 1983 Feb 01; 33(1):227-40. PubMed ID: 6876518 [Abstract] [Full Text] [Related]
11. Arachidonic acid-induced human platelet aggregation and prostaglandin formation. Silver MJ, Smith JB, Ingerman C, Kocsis JJ. Prostaglandins; 1973 Dec 01; 4(6):863-75. PubMed ID: 4205973 [No Abstract] [Full Text] [Related]
12. An endoperoxide aggregator (Lass), formed in platelets in response to thrombotic stimuli: purification, identification and unique biological significance. Willis AL, Vane FM, Kuhn DC, Scott CG, Petrin M. Prostaglandins; 1974 Dec 25; 8(6):453-507. PubMed ID: 4471695 [No Abstract] [Full Text] [Related]
17. The effects of arachidonic acid, prostaglandin E2 and prostaglandin F2alpha on the longitudinal stomach strip of the rat. Splawinski JA, Nies AS, Sweetman B, Oates JA. J Pharmacol Exp Ther; 1973 Dec 02; 187(3):501-10. PubMed ID: 4203719 [No Abstract] [Full Text] [Related]
18. Some biological effects of prostaglandin endoperoxide analogs. Malmsten C. Life Sci; 1976 Jan 15; 18(2):169-76. PubMed ID: 1256232 [No Abstract] [Full Text] [Related]